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Quantifying Acute Myocardial Injury Using Ratiometric Fluorometry
Abstract
Early reperfusion is the best therapy for myocardial infarction (MI). Effectiveness, however, varies
significantly between patients and has implications for long-term prognosis and treatment. A technique to
assess the extent of myocardial salvage after reperfusion therapy would allow for high-risk patients to be
identified in the early post-MI period. Mitochondrial dysfunction is associated with cell death following
myocardial reperfusion and can be quantified by fluorometry. Therefore, we hypothesized that variations in
the fluorescence of mitochondrial nicotinamide adenine dinucleotide (NADH) and flavoprotein (FP) can be
used acutely to predict the degree of myocardial injury. Thirteen rabbits had coronary occlusion for 30 min
followed by 3 h of reperfusion. To produce a spectrum of infarct sizes, six animals were infused cyclosporine A
prior to ischemia. Using a specially designed fluorometric probe, NADH and FP fluorescence were measured
in the ischemic area. Changes in NADH and FP fluorescence, as early as 15 min after reperfusion, correlated
with postmortem assessment infarct size (r=0.695, p<0.01). This correlation strengthened with time
(r=0.827, p<0.01 after 180 min). Clinical application of catheter-based myocardial fluorometry may provide a
minimally invasive technique for assessing the early response to reperfusion therapy.
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Abstract—Early reperfusion is the best therapy for myocar-
dial infarction (MI). Effectiveness, however, varies significantly
between patients and has implications for long-term prognosis and
treatment. A technique to assess the extent of myocardial salvage
after reperfusion therapy would allow for high-risk patients to
be identified in the early post-MI period. Mitochondrial dysfunc-
tion is associated with cell death following myocardial reperfusion
and can be quantified by fluorometry. Therefore, we hypothesized
that variations in the fluorescence of mitochondrial nicotinamide
adenine dinucleotide (NADH) and flavoprotein (FP) can be used
acutely to predict the degree of myocardial injury. Thirteen rabbits
had coronary occlusion for 30 min followed by 3 h of reperfusion.
To produce a spectrum of infarct sizes, six animals were infused
cyclosporine A prior to ischemia. Using a specially designed fluo-
rometric probe, NADH and FP fluorescence were measured in the
ischemic area. Changes in NADH and FP fluorescence, as early as
15 min after reperfusion, correlated with postmortem assessment
infarct size (r = 0.695, p < 0.01). This correlation strengthened
with time (r = 0.827, p < 0.001 after 180 min). Clinical appli-
cation of catheter-based myocardial fluorometry may provide a
minimally invasive technique for assessing the early response to
reperfusion therapy.
Index Terms—Apoptosis, fluorometery, mitochondrial disrup-
tion, mitochondrial redox state, myocardial infarction, myocardial
reperfusion injury.
I. INTRODUCTION
OVER THE past 35 years, techniques to identify and revas-cularize ischemic myocardium have been developed to a
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high level. Despite this, a mass epidemic of congestive heart
failure (CHF) due to coronary disease has developed [1]. Five
million Americans suffer from CHF with 550 000 new cases
diagnosed each year. Sixty-eight percent of these cases are due
to coronary disease [1]. After myocardial infarction (MI), CHF
is preceded by infarct expansion (i.e., the infarct stretches), pro-
gressive generalized left ventricular (LV) dilatation, and contrac-
tile dysfunction. This deleteriously progressive phenomenon has
been termed postinfarction LV remodeling [2].
Once the remodeling process is established, the symptoms of
CHF ensuing five-year survival, even with the most aggressive
medical and surgical therapy, is about 50% [3]. These dismal
results have generated a strong interest in developing mechani-
cal strategies for preventing infarct expansion, the resulting LV
dilation, and failure.
Recent work in chronic large animal heart failure models
has demonstrated that early restraint to prevent infarct stretch-
ing significantly limits ventricular dilation and preserves func-
tion [4]–[6]. Despite compelling experimental data, these tech-
niques currently have limited clinical applicability due to an
inability to identify patients early (days after infarction) at risk
for remodeling. While infarct size has long been understood
to correlate with the ultimate degree of ventricular remodel-
ing [7], [8], it is a difficult parameter to quantify particularly
early after reperfusion therapy.
Mitochondrial dysfunction and disruption are known to be in-
timately involved in both necrotic and apoptotic processes that
lead to cell death following myocardial reperfusion [9], [10].
As a result, in vivo quantitative assessment of mitochondrial
function may provide a method for assessing infarct size above
what is currently provided by angiography and echocardiogra-
phy [11], [12].
Toward this end, we have developed an optical catheter de-
vice to acquire fluorescence signals of the intrinsic mitochon-
drial fluorophores, nicotinamide adenine dinucleotide (NADH),
and flavoprotein (FP). The ratio of these fluorescence signals
(FP/FP + NADH), defined as the redox ratio (RR), has been
shown to correlate with different metabolic states and mitochon-
drial function [13], [14]. Additionally, the RR has been shown to
undergo an oxidative shift in tumor cells with mitochondrial dys-
function associated with apoptosis [15]. We hypothesize that the
RR within the ischemic zone, as measured by our device, can
be directly correlated with infarct size early after myocardial
reperfusion. Proof of such a correlation would indicate fiber-
optically assessed mitochondrial fluorescence to be a quanti-
tative tool to assess myocardial injury without invasive tissue
biopsy.
0018-9294/$25.00 © 2009 IEEE
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II. MATERIALS AND METHODS
A well-characterized rabbit model of ischemia-reperfusion
injury was used [16]. In order to induce a wider range of mi-
tochondrial disruption and myocardial injury, half the animals
were treated prior to ischemia with Cyclosporin A (CsA). In
this rabbit model, CsA has been shown to inhibit mitochondrial
permeability transition pore opening at reperfusion following
myocardial ischemia resulting in significantly less necrotic and
apoptotic myocyte death [17].
The combination of within group (small differences in is-
chemic zone size due to varying coronary anatomy) and be-
tween group (CsA protection) provides a desirable spectrum of
myocardial insults with which to correlate RR measurements.
A. Surgical Protocol
Animals are treated under experimental protocols approved
by the University of Pennsylvania’s Institutional Animal Care
and Use Committee (IACUC) and in compliance with National
Institutes of Health Publication No. 85-23, revised 1996.
Thirteen New Zealand white rabbits (3.2–4.0 kg) were studied
in two experimental groups:
1) untreated (UnT) (n = 7): 1-h continuous 20 mL infusion
of saline given intravenously prior to ischemia;
2) cyclosporine A (CsA) treatment (n = 6): 1-h continuous
20 mL infusion of a solution of saline and CsA (25 mg/kg)
given intravenously prior to ischemia.
Anesthesia was induced with intramuscular ketamine (70–
100 mg/kg), glycopyrrolate (0.01 mg/kg) and buprenorphine
(0.05 mg/kg). After oral endotracheal intubation, animals
were mechanically ventilated (Hallowell EMC Model AWS,
Pittsfield, MA, USA) with air enriched with 0.6 L/min of oxy-
gen. Anesthesia was maintained with continuous ketamine infu-
sion (20 mg/kg/hr IV). A high-fidelity pressure transducer (Mil-
lar Instruments Inc. Houston, TX, USA) was placed in the left
ventricle via carotid artery for continuous LV pressure measure-
ment. Peripheral arterial blood pressure, heart rate, and surface
electrocardiogram (ECG) were also continuously monitored
(Hewlett Packard 78534C, Palo Alto, CA, USA) and recorded
(Sonometrics Inc., London, ON, Canada). Left atrial blood tem-
perature was measured with an electrical thermometer (Ther-
malert TH-8 Physiotemp Instrument, Clifton, NJ, USA) and was
maintained between 39 ◦C to 40 ◦C (normal rabbit body tem-
perature) with a high efficiency water blanket (Medi-Therm III,
Gaymar Industries Inc., Orchard Park, NY, USA).
Next, all animals received a 1-h, continuous 20 mL infusion
of a phosphate buffered saline (PBS) vehicle (UnT), 25 mg/kg
of CsA. A left thoracotomy was performed in the fourth in-
tercostal space and the heart was exposed. A pledgetted suture
(3-0 Ti-cron, U.S. Surgical, Norwalk, CT, USA) was passed
around a large branch of the circumflex coronary artery at a dis-
tance 50% from the base of the heart toward the apex. Myocar-
dial ischemia was achieved by tightening the coronary artery
snare and confirmed by ST elevations on ECG and by the dis-
tinct color change of the myocardium. After 30 min of ischemia,
the coronary artery snare was released and the myocardium was
reperfused for 180 min.
Fig. 1. Two-wavelength time-shared fluorometer in rabbit heart ratiometric
measurements.
To provide a specimen of normal myocardium, one rabbit un-
derwent the same protocol as the UnT group with the exception
that no coronary was ligated and no ischemia induced.
B. Myocardial Fluorescence Spectroscopy
Fluorescence spectroscopy of rabbit myocardium in vivo was
conducted with a fluorometer (Fig. 1). This fluorometer is a
mobile optical–electrical apparatus that collects fluorescence
signals of any type of tissue through a 3-mm-tip light guide.
The incident light is a broadband mercury arc lamp that can
be filtered at four different wavelengths by an air turbine fil-
ter wheel rotating at 50 Hz. Consequently, up to four signals
could be multiplexed to a photodetector in order to make four-
wavelength channel optical measurements of tissue metabolism
as shown in Fig. 1. In this experiment, two channels are used
for excitation and the other two for emission signals. The light
intensity that is incident on tissue at the fiber tip is 3 µW.
In cardiac fluorometry experiments, the excitation wave-
lengths of FP and NADH are obtained by filtering the mercury
arc lamp at 436 nm and 366 nm resonance lines by interference
filters 440DF20 and 365HT25 (Omega Optical, Brattleboro,
VT, USA). The fluorescence intensities are then detected by a
photomultiplier tube (PMT model R928, Hamamatsu, Japan),
converted to an electric voltage, digitized, and displayed. A
standard protocol for the fluorometer calibration is used at the
beginning of each single experiment. Fluorescent standards are
used from which we measure the fluorescent light at the wave-
lengths of interest for the upcoming experiment. We take these
standard measurements into account if any adjustment factor is
needed to apply to the experimental results. Specific instrument
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Fig. 2. Double staining technique used to identify the area at risk (AR) and
the region of infarction in both the UnT group (A) and the CSA group (B). Both
hearts have been sliced perpendicular to the long axis. Blue-purple myocardium
has been stained by both Evans blue dye indicating it is outside the area at risk
and by triphenyl-tetrazolium (TTC) indicating it is viable. Within the area at
risk (no blue staining) viable myocardium has been stained dark red by TTC
while the pale infracted regions have not. Notice the smaller infarct region in
the CSA group.
specifications are kept the same for all the experiments (e.g.
PMT high voltage, channel gain factors, etc.).
The fluorometer probe was placed on the epicardial surface in
the center of the anticipated region of ischemia and continuous
recording of the fluorescence signals for FP and NADH signals
was performed during baseline (60 min infusion of saline or
CsA), ischemia (30 min), and reperfusion (180 min). The redox
ratio is calculated as FP/(FP + NADH) every 5 min from the
continuously recorded FP and NADH. All the redox ratio data
points are then normalized by the value at time point t = 0.
These normalized redox ratios (RRs) in each group (UnT = 7
and CsA = 6) are averaged and expressed as mean ± standard
deviation at 5-min time points for statistical analysis and 10-
minute intervals for spectroscopic graphs.
C. Analysis of Area at Risk and Infarct Size
At the end of the protocol, the coronary snare was reapplied,
vascular clamps were used to occlude the aorta, pulmonary
artery, and inferior vena cava, and the right atrium was incised.
Five milliliters of Evans blue dye (1%) (Sigma, St. Louis, MO,
USA) was injected via the left atrium to delineate the ischemic
myocardial risk area (AR). The heart was arrested with an
intraatrial bolus of 20 mEq of potassium chloride and was ex-
planted. The left ventricle was sectioned perpendicular to its
long axis into six to seven slices. Fig. 2 illustrates these slices
stained by double staining technique for identification of area
at risk. The thickness of each slice was measured with a digi-
tal micrometer and a standardized digital photograph was taken
(Casio EX-Z850, Tokyo, Japan). Infarct area (I/AR) was de-
lineated by photographing and measuring the slices after 20
min of incubation in 2% triphenyltetrazolium chloride (TTC) at
37 ◦C. All photographs were imported into an image analysis
program (Image Pro Plus, Media Cybernetics, Silver Spring,
MD, USA) and computerized planimetry was performed. The
AR is expressed as a percentage of the LV, and the infarct size
is expressed as a percentage of the AR (I/AR).
D. Transmission Electron Microscopy
To confirm the effect of CsA on mitochondrial integrity, punch
biopsies from directly under fluorometric probe were taken from
two animals in the UnT group, two animals in the CsA group,
and the one normal animal at the conclusion of the reperfu-
sion protocol. Each of these biopsies was preserved in electron
microscopy fixative (2.5% glutaraldehyde, 2.0% paraformalde-
hyde, 0.1 M sodium cacodylate) for 24 h at 4 ◦C. After several
washes in 0.1 M NaCaC, samples were postfixed with buffered
2% osmium tetroxide for 1 h at 4◦C. Subsequent washes in
0.1 M NaCaC, H2O, and 2% aqueous uranyl acetate were then
used to destain samples. Tissue samples were dehydrated in
serial washes of EtOH and propylene oxide, prior to a slow in-
filtration with EPON 812. Finally, samples were cured at 70 ◦C
for 48 h.
Cured samples were submitted to the Biomedical Imaging
Core Facility at the University of Pennsylvania, where they were
cut, stained, and imaged on a Jeol-10-10 transmission electron
microscope (Jeol Ltd, Akishima, Japan). Random images were
captured from each sample for comparative analysis. To assess
the degree of mitochondrial disruption, five random images of
mitochondria at 30 000X were captured from two control, two
CsA-treated, and one normal rabbit. The number of disrupted
mitochondria was tallied, along with the total number of mi-
tochondria. The percent disrupted mitochondrion (PDM) was
then determined, averaged for each group, and reported.
E. Statistical Analysis
Group results for the RR, I/AR and PDM are expressed
as the mean ± standard deviation. The RR was calculated at
5 min intervals during the entire experiment for all animals. To
assess between-group differences in the RR during preischemia,
ischemia, and postischemia, analysis of variance (ANOVA) was
used. Where ANOVA revealed significant differences, Student’s
T -test was used to compare the groups at individual time points.
Postmortem values for I/AR and PDM were compared using
Student’s T -test.
At each time point, the RR was correlated with both the
I/ARs using Pearson’s correlation test. A p-value < 0.05 was
considered statistically significant. The software package used
for the statistical analysis was SPSS version 11.0 for Windows
(SPSS Inc., Chicago IL, USA).
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Fig. 3. Comparison of area at risk and infarct sizes between the UnT group and
the CsA group. Values are means ± standard deviation. The AR is expressed as
a percentage of the LV (AR/LV), and the infarct size is expressed as a percentage
of the AR (I/AR). Statistically significant difference from UnT group (p < 0.01)
is indicated by ∗.
III. RESULTS
A. Infarct Size Measurements
The two-group model produced a varying degree of infarcted
myocardium. The AR was similar in both groups: 27.0± 8.1%
in the UnT group and 26.5± 9.1% in the CsA group. The I/AR
was significantly smaller in the CsA group than in the UnT
(39.1± 4.4% vs. 53.4± 4.7%, p < 0.0001) (Fig. 3).
B. Mitochondrial Disruption
The protective effect of CsA on reperfused myocardium was
also quite evident in the myocardial samples studied with EM
(Fig. 4). The majority of the myocytes in all three groups (one
normal, two UnT, and two CsA-treated rabbits) had nuclei with
a ruffled membrane and normally distributed heterochromatin.
The nuclear membranes of the normal and the CsA groups
were also smooth, while several abnormally shaped nuclei were
found in the UnT group. Normally, the nuclear cap, or region
surrounding the nucleus, is tightly packed with mitochondria.
Although not as densely packed with mitochondria as the nor-
mal group, tightly packed mitochondria were still present in the
nuclear caps of the CsA group. Most mitochondria of the CsA-
treated animals had well-defined outer membranes. Although
a small percentage of the mitochondria had dilated cristae, the
majority of the CsA cristae exhibited normal characteristics. The
nuclear caps of the UnT group were either absent of mitochon-
dria or possessed mitochondria with disrupted outer membranes
and tightly packed cristae, vacuolated mitochondria with poorly
defined outer membranes, or mitochondria absent of an outer
membrane and unraveling cristae. For all three groups, the mi-
tochondria between the muscle fibers possessed characteristics
similar to what was found in the nuclear cap of the respective
group. The percent disrupted mitochondria for the UnT group
was 53.31%± 16.47%, for the CsA group, 19.71%± 9.64%,
and for the normal group 1.65% (Fig. 5).
Fig. 4. Comparison of mitochondrial changes in the electron microscopy
imaging between the UnT group, the CsA group, and normal group. Normally,
the nuclear cap, or region surrounding the nucleus, is tightly packed with mi-
tochondria (C, F). Although not as densely packed with mitochondria as the
normal group, tightly packed mitochondria were still present in the nuclear caps
of the CsA group (B). Most mitochondria of the CsA-treated animals had well-
defined outer membranes. Although a small percentage of the mitochondria had
dilated cristae, the majority of the CsA cristae exhibited normal characteristics
(E). The nuclear caps of the UnT group were either absent of mitochondria
or possessed mitochondria with disrupted outer membranes and tightly packed
cristae, vacuolated mitochondria with poorly defined outer membranes, or mi-
tochondria absent of an outer membrane and unraveling cristae (A, D). For all
three groups, the mitochondria between the muscle fibers possessed charac-
teristics similar to what was found in the nuclear cap of the respective group.
(A) UnT-12000X. (B) CsA-12000X. (C) Normal-12000X. (D) UnT-30000X.
(E) CsA-30000X. (F) Normal-30000X.
Fig. 5. Comparison of the percent disrupted mitochondria (PDM) between
the UnT group, the CsA group, and normal group. Values are means ± standard
deviation. PDM = percent disrupted mitochondria.
C. Redox Fluorometry
Fig. 6 presents the RR at 10 min intervals during the en-
tire protocol. The RR remained constant in both groups during
the pre-ischemic CsA/saline infusion period demonstrating that
CsA had no effect on the mitochondrial metabolic state of nor-
mally perfused myocardium.
In both groups, the RR drops immediately with the onset of
ischemia and continues to drop steadily during the entire 30 min.
This is consistent with marked reduction in the oxidative state
of the fluorophores due to decreased oxygen availability. That
is, NADH and FP remain in their reduced form due to backup of
Authorized licensed use limited to: University of Pennsylvania. Downloaded on October 13, 2009 at 11:16 from IEEE Xplore.  Restrictions apply. 
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Fig. 6. Comparison of mean normalized redox ratio between the UnT group
and CsA group throughout the experiment. Statistically significant difference
between the UnT and CsA groups (p < 0.05) is indicated by filled circle and
triangle. Error bars represent twice the standard deviation.
TABLE I
CORRELATIONS BETWEEN RR AND I/AR AFTER REPERFUSION
the electron transport chain. The rate at which the RR decreased
was slightly less in the CsA group (Fig. 6), but this trend did not
reach statistical significance.
With the reinstitution of blood flow, the RR increased im-
mediately in both groups. In the UnT group, the RR increased
persistently by 53.1± 6.8% over normal during the 180 min
of reperfusion. This drastic increase in the RR represents a
“hyper-oxidation” of fluorophores and is indicative of dysfunc-
tional mitochondria that are unable to reduce NAD+ and FP
thus preventing their entry into the electron transport chain and
ultimately the production of adenosine triphosphate. In the CsA
group, the RR ratio only increases by 17.0± 11.0% of normal
demonstrating less mitochondrial dysfunction.
During the first 15 min after reperfusion the RR increases
almost linearly in both groups but with a much greater slope in
the UnT group. After 15 min of reperfusion, the RR of the UnT
group is significantly greater than that of the CsA group. After
30 min, the RR changes very little in the CsA group.
Table I demonstrates the correlation between the RR and
I/AR at 15-min time intervals after reperfusion. It can be seen
that as early as 15 min after reperfusion, the RR ratio correlates
Fig. 7. Plot of infarct size versus normalized redox ratio at 15 min of reperfu-
sion in the UnT group and the CsA group.
Fig. 8. Plot of infarct size versus normalized redox ratio at 180 min of reper-
fusion in the UnT group and the CsA group.
strongly with infarct size. Figs. 7 and 8 are scatter plots of the RR
versus the I/AR that demonstrate the predictive strength of the
correlation at 15 and 180 min after reperfusion, respectively.
IV. DISCUSSION
Mitochondrial permeability transition (MPT) pore opening
is recognized as a pivotal event in necrotic and apoptotic cell
death [18], [19]. Following myocardial ischemia-reperfusion
injury, opening of this nonspecific pore results in inner mem-
brane potential collapse, uncoupling of the respiratory chain,
and efflux of small molecules such as cytochrome c and other
proapoptotic factors [20]. CsA is a powerful inhibitor of the
MPT pore, and several reports indicate that it protects the iso-
lated heart from ischemia-reperfusion injury [17]. In this study,
the protective role of CsA was confirmed in vivo and exploited to
provide an experimental model with a spectrum of reperfusion-
induced mitochondrial dysfunction and resulting myocardial in-
jury. This model was used to test the hypothesis that changes
in mitochondrial NADH and FP fluorescence can be measured
and correlated with myocardial injury.
Our data indicates that myocardial reperfusion injury is as-
sociated with mitochondrial disruption, which is significantly
blunted by CsA, and that this injury correlates very strongly
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with the RR as measured by fluorometry. This is particularly
compelling considering that the fluorometric measurements of
NADH and FP were made over a relatively small epicardial re-
gion of the area at risk. We found it equally interesting that even
very early after reperfusion (15 min), the RR began to correlate
with infarct size at 3 h postreperfusion.
These data provide convincing evidence that fluorometry can
be used to clinically assess myocardial injury noninvasively
without tissue biopsy. Such a tool will provide a better early
evaluation of the effectiveness of reperfusion therapy and po-
tentially identify patients that are at increased risk for postinfarc-
tion ventricular remodeling. Early identification of such patients
would allow the institution of more aggressive infarct restraint
procedures to prevent heart failure than would be justifiable
without proper patient identification.
Apoptotic-induced mitochondrial dysfunction is associated
with established chronic heart failure [21] as well as myocar-
dial rejection after heart transplantation [22]. Both these disease
states are currently treated with complex pharmacological strate-
gies that can be hard to optimize. Considering the findings of
this study, it is possible that fluorometry may be used to assess
and monitor the progression of these diseases without tissue
biopsy and allow physicians to make more informed decisions
regarding drug selection and dosing.
To prove the clinical applicability of this technology, we are
currently in the process of designing human experiments in
which the redox ratio will be correlated with mitochondrial dis-
ruption as measured by electron microscopy in cardiovascular
specimens. The first human experiments will be conducted on
patients with end-stage heart failure requiring placement of a
ventricular assist device (VAD). During VAD placement, a por-
tion of the failing LV is routinely removed. Prior to excision
of the myocardium, the redox ratio will be measured. The my-
ocardium will then be removed and assessed for mitochondrial
disruption using the electron microscopic techniques described
in this manuscript and the two measurements correlated.
While development hurdles persist, one can envision a
catheter-based fluorometer that will be introduced via standard
percutaneous venous or arterial techniques to assess the myocar-
dial injury associated with reperfusion, ventricular remodeling,
and allograft rejection. We believe that in human application,
transvascular approaches will allow the fluorometric catheter to
be placed directly on the tissue of interest and that signal quality
will be very similar to those reported in this manuscript. Such
a technology would improve the care of these very complex
patients while at the same time minimizing their discomfort and
treatment risk.
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